Adherence characteristics after abnormal screening results between mammogram and papanicolaou test groups

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The purpose of this study was to evaluate whether the adherence concerns related to follow-up were different between groups of women after abnormal screening results of mammography (Mam) and Papanicolaou (Pap) test. Taiwanese women with abnormal Mam screening results (n = 42) and abnormal Pap test results (n = 109) provided data via a self-administered survey. Data were collected in 2005. After providing informed consent, women completed the AFAR, an 18 item questionnaire that measured the Adherence concerns of Follow-up after Abnormal screening Results. The results showed that (1) for both Mam and Pap test groups, the most important adherence concern for clinical follow-up after abnormal screening results is disease related, followed by others' response and resource accessibility; and (2) in these 2 clinical follow-up groups, women in the Mam group were more likely to be concerned with all of the 18 adherence factors than those in the Pap test group (OR, 2.46-9.86). The most important adherence concern on clinical follow-up after abnormal screening results for Mam and Pap test women is disease related. Mammography women considered significantly more adherence concerns than Pap test women. These differences imply that improving follow-up after Mam or Pap screen may require different interventions.

Original languageEnglish
Pages (from-to)437-445
Number of pages9
JournalCancer Nursing
Volume32
Issue number6
DOIs
Publication statusPublished - 2009 Nov 1

Fingerprint

Papanicolaou Test
Mammography
Informed Consent

All Science Journal Classification (ASJC) codes

  • Oncology
  • Oncology(nursing)

Cite this

@article{5b281736d6004e2a971bf6fd35b3b61d,
title = "Adherence characteristics after abnormal screening results between mammogram and papanicolaou test groups",
abstract = "The purpose of this study was to evaluate whether the adherence concerns related to follow-up were different between groups of women after abnormal screening results of mammography (Mam) and Papanicolaou (Pap) test. Taiwanese women with abnormal Mam screening results (n = 42) and abnormal Pap test results (n = 109) provided data via a self-administered survey. Data were collected in 2005. After providing informed consent, women completed the AFAR, an 18 item questionnaire that measured the Adherence concerns of Follow-up after Abnormal screening Results. The results showed that (1) for both Mam and Pap test groups, the most important adherence concern for clinical follow-up after abnormal screening results is disease related, followed by others' response and resource accessibility; and (2) in these 2 clinical follow-up groups, women in the Mam group were more likely to be concerned with all of the 18 adherence factors than those in the Pap test group (OR, 2.46-9.86). The most important adherence concern on clinical follow-up after abnormal screening results for Mam and Pap test women is disease related. Mammography women considered significantly more adherence concerns than Pap test women. These differences imply that improving follow-up after Mam or Pap screen may require different interventions.",
author = "Su-Ying Fang and Bih-Ching Shu",
year = "2009",
month = "11",
day = "1",
doi = "10.1097/NCC.0b013e3181ab5747",
language = "English",
volume = "32",
pages = "437--445",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Adherence characteristics after abnormal screening results between mammogram and papanicolaou test groups. / Fang, Su-Ying; Shu, Bih-Ching.

In: Cancer Nursing, Vol. 32, No. 6, 01.11.2009, p. 437-445.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adherence characteristics after abnormal screening results between mammogram and papanicolaou test groups

AU - Fang, Su-Ying

AU - Shu, Bih-Ching

PY - 2009/11/1

Y1 - 2009/11/1

N2 - The purpose of this study was to evaluate whether the adherence concerns related to follow-up were different between groups of women after abnormal screening results of mammography (Mam) and Papanicolaou (Pap) test. Taiwanese women with abnormal Mam screening results (n = 42) and abnormal Pap test results (n = 109) provided data via a self-administered survey. Data were collected in 2005. After providing informed consent, women completed the AFAR, an 18 item questionnaire that measured the Adherence concerns of Follow-up after Abnormal screening Results. The results showed that (1) for both Mam and Pap test groups, the most important adherence concern for clinical follow-up after abnormal screening results is disease related, followed by others' response and resource accessibility; and (2) in these 2 clinical follow-up groups, women in the Mam group were more likely to be concerned with all of the 18 adherence factors than those in the Pap test group (OR, 2.46-9.86). The most important adherence concern on clinical follow-up after abnormal screening results for Mam and Pap test women is disease related. Mammography women considered significantly more adherence concerns than Pap test women. These differences imply that improving follow-up after Mam or Pap screen may require different interventions.

AB - The purpose of this study was to evaluate whether the adherence concerns related to follow-up were different between groups of women after abnormal screening results of mammography (Mam) and Papanicolaou (Pap) test. Taiwanese women with abnormal Mam screening results (n = 42) and abnormal Pap test results (n = 109) provided data via a self-administered survey. Data were collected in 2005. After providing informed consent, women completed the AFAR, an 18 item questionnaire that measured the Adherence concerns of Follow-up after Abnormal screening Results. The results showed that (1) for both Mam and Pap test groups, the most important adherence concern for clinical follow-up after abnormal screening results is disease related, followed by others' response and resource accessibility; and (2) in these 2 clinical follow-up groups, women in the Mam group were more likely to be concerned with all of the 18 adherence factors than those in the Pap test group (OR, 2.46-9.86). The most important adherence concern on clinical follow-up after abnormal screening results for Mam and Pap test women is disease related. Mammography women considered significantly more adherence concerns than Pap test women. These differences imply that improving follow-up after Mam or Pap screen may require different interventions.

UR - http://www.scopus.com/inward/record.url?scp=73649104087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649104087&partnerID=8YFLogxK

U2 - 10.1097/NCC.0b013e3181ab5747

DO - 10.1097/NCC.0b013e3181ab5747

M3 - Article

VL - 32

SP - 437

EP - 445

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 6

ER -